Patent 7112336 was granted and assigned to Bayer Healthcare on September, 2006 by the United States Patent and Trademark Office.
The present invention relates to a solid dispersion of quinolone- or naphthyridonecarboxylic acids in an insoluble matrix representative of a shellac, and methods preparing and using the same in masking the taste and improving the uptake by animals.